| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 10T6626FRK |
| InChI Key | YKPYIPVDTNNYCN-INIZCTEOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H21N3O5S2 |
| Molecular Weight | 423.52 |
| AlogP | 2.26 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 108.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 28.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Metallo protease
Metallo protease MAM clan
Metallo protease M10A subfamily
|
- | 5-48 | - | 0-0 | - | |
|
Enzyme
Protease
Metallo protease
Metallo protease MAM clan
Metallo protease M12B subfamily
|
- | 6-16600 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 192329-42-3 |
| ChEBI | 138885 |
| ChEMBL | CHEMBL75094 |
| DrugBank | DB05100 |
| EPA CompTox | DTXSID3043946 |
| FDA SRS | 10T6626FRK |
| Guide to Pharmacology | 6505 |
| PDB | PN0 |
| PubChem | 466151 |
| SureChEMBL | SCHEMBL115696 |
| ZINC | ZINC000000580328 |